PharmaBoardroom - Evolving Compassionate Use and Named Patient Programs Across Asia Pacific
Ordinance on Medicinal Products for Compassionate Use
Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center | PLOS ONE
Compassionate Use and other Managed Access Concepts - GMP Journal
Compassionate use: Providing access to much needed treatments | Novartis
I'm Willing To Try Anything': Compassionate Use Access To Experimental Drugs And The Misguided Mission Of Right-To-Try Laws | Health Affairs
Proportion of Gaucher Patients per country receiving their treatment on... | Download Scientific Diagram
PDF) Compassionate use programs in Italy: Ethical guidelines
The Global Guide to Compassionate Use Programs
Compassionate use: Providing access to much needed treatments | Novartis
Regeneron Compassionate Use Policy
Compassionate use of drugs and medical devices in the United States, the European Union and Japan - ScienceDirect
Summary of 'compassionate use' regulations in ten European countries | Download Table
Compassionate use in Europe
Compassionate Use Policy - BioMarin
Compassionate Use Programmes - Paul-Ehrlich-Institut
What is a Compassionate Use Program? - WEP Clinical
Understanding the challenges and ethical aspects of compassionate use of drugs in emergency situations Goyal PK, Mathur R, Medhi B - Indian J Pharmacol
Compassionate Use and other Managed Access Concepts - GMP Journal
Regulatory Explainer: FDA's Expanded Access (Compassionate Use) Program | RAPS
A case for compassionate use: When unapproved drugs are the only hope
Legal basis, terminologies, and regulatory evidence for compassionate... | Download Scientific Diagram
Compassionate use - EURORDIS
The EU's compassionate use mechanism for drugs. | Download Table
Compassionate use programs and the European regulatory system Filip Josephson M.D., Ph.D. Clinical Assessor. - ppt download
